Nagi Bioscience

Nagi Bioscience

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.7M

Overview

Nagi Bioscience is a platform and services company focused on revolutionizing aging and longevity research through automation and standardization of the C. elegans model. Its core offerings include the SydLab™ One, a fully automated benchtop platform for in-house use, and the Nagi™ C-Age and B-Age assays available via its contract research organization (CRO) services. By providing multi-dimensional, reproducible data in days rather than months, Nagi aims to de-risk and accelerate the development of therapeutic interventions and health claims. The company leverages over 15 years of domain expertise and Swiss engineering precision to position itself as a critical partner in the rapidly growing longevity sector.

LongevityAge-Related Diseases

Technology Platform

Automated, high-throughput in vivo testing platform using C. elegans for simultaneous measurement of lifespan, healthspan, and biological age, powered by proprietary hardware, software, and AI analytics.

Funding History

2
Total raised:$3.7M
Seed$3.2M
Grant$500K

Opportunities

The company is positioned in the high-growth longevity and anti-aging market, where demand for fast, ethical, and predictive preclinical data is surging.
The global shift towards New Approach Methodologies (NAMs) creates a regulatory tailwind for its C.
elegans-based platform.
Expansion opportunities include broadening its assay menu, leveraging its aggregated data for AI-driven discovery, and scaling its instrument sales globally.

Risk Factors

Key risks include competition from other research tool providers and in-house methods, and the perennial challenge of validating the translational predictability of C.
elegans data for human health outcomes.
The business model also faces scaling challenges, particularly in transitioning from a service-heavy CRO to a capital equipment sales model for its platform.

Competitive Landscape

Nagi competes with other C. elegans CROs and academic service cores, as well as providers of alternative model organism platforms (e.g., fruit fly, zebrafish). Its primary differentiation is the full automation, multi-endpoint measurement, and AI-powered biological age analysis integrated into a single workflow. It also competes indirectly with traditional rodent CROs by offering a faster, cheaper, ethical alternative for early-stage discovery.